Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:12 pm Sale |
2024-12-31 | 13G | Keros Therapeutics, Inc. KROS |
ALKEON CAPITAL MANAGEMENT LLC | 1,101,000 2.700% |
-397,907 (-26.55%) |
Filing History |
| 2024-11-13 09:48 am Purchase |
2024-09-30 | 13G | OneStream, Inc. Class A Common Stock OS |
ALKEON CAPITAL MANAGEMENT LLC | 4,900,213 9.990% |
4,900,213 (New Position) |
Filing History |
| 2024-11-13 09:45 am Sale |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
ALKEON CAPITAL MANAGEMENT LLC | 3,325,004 4.800% |
-439,216 (-11.67%) |
Filing History |
| 2024-11-13 09:42 am Purchase |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
ALKEON CAPITAL MANAGEMENT LLC | 3,904,096 5.500% |
300,000 (+8.32%) |
Filing History |
| 2024-02-13 6:49 pm Sale |
2023-12-31 | 13G | RingCentral, Inc. RNG |
ALKEON CAPITAL MANAGEMENT LLC | 1,528,157 1.800% |
-3,274,031 (-68.18%) |
Filing History |
| 2024-02-13 6:43 pm Purchase |
2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
ALKEON CAPITAL MANAGEMENT LLC | 3,604,096 6.600% |
1,204,844 (+50.22%) |
Filing History |
| 2024-02-13 6:38 pm Purchase |
2023-12-31 | 13G | Keros Therapeutics, Inc. KROS |
ALKEON CAPITAL MANAGEMENT LLC | 1,498,907 5.000% |
106,505 (+7.65%) |
Filing History |
| 2024-02-13 6:30 pm Purchase |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
ALKEON CAPITAL MANAGEMENT LLC | 3,764,220 6.800% |
520,305 (+16.04%) |
Filing History |
| 2023-02-13 10:54 am Purchase |
2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
ALKEON CAPITAL MANAGEMENT LLC | 3,243,915 6.900% |
764,244 (+30.82%) |
Filing History |
| 2023-02-13 10:16 am Purchase |
2022-12-31 | 13G | RingCentral, Inc. RNG |
ALKEON CAPITAL MANAGEMENT LLC | 4,802,188 5.600% |
537,095 (+12.59%) |
Filing History |
| 2023-02-13 10:15 am Purchase |
2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
ALKEON CAPITAL MANAGEMENT LLC | 2,399,252 6.100% |
2,399,252 (New Position) |
Filing History |
| 2023-02-13 10:13 am Purchase |
2022-12-31 | 13G | Keros Therapeutics, Inc. KROS |
ALKEON CAPITAL MANAGEMENT LLC | 1,392,402 5.100% |
1,392,402 (New Position) |
Filing History |
| 2023-02-13 10:11 am Sale |
2022-12-31 | 13G | AVAYA HLDGS CORP COM AVYAQ |
ALKEON CAPITAL MANAGEMENT LLC | 0 0.000% |
-5,898,941 (Position Closed) |
Filing History |
| 2022-02-11 8:25 pm Purchase |
2021-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
ALKEON CAPITAL MANAGEMENT LLC | 2,479,671 7.100% |
192,041 (+8.39%) |
Filing History |
| 2022-02-11 8:19 pm Purchase |
2021-12-31 | 13G | RingCentral, Inc. RNG |
ALKEON CAPITAL MANAGEMENT LLC | 4,265,093 5.200% |
4,265,093 (New Position) |
Filing History |
| 2022-02-11 8:12 pm Purchase |
2021-12-31 | 13G | AVAYA HLDGS CORP COM AVYAQ |
ALKEON CAPITAL MANAGEMENT LLC | 5,898,941 6.900% |
5,898,941 (New Position) |
Filing History |
| 2021-02-11 5:50 pm Sale |
2020-12-31 | 13G | Luckin Coffee Inc. LKNCY |
ALKEON CAPITAL MANAGEMENT LLC | 0 0.000% |
-32,032,416 (Position Closed) |
Filing History |
| 2021-02-11 4:54 pm Purchase |
2020-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
ALKEON CAPITAL MANAGEMENT LLC | 2,287,630 6.600% |
2,287,630 (New Position) |
Filing History |